US firm Codexis and Shasun Chemicals and Drugs of India have signed
a manufacturing and supply agreement for a pharmaceutical
intermediate for a generic drug.
The discovery of a new batch of counterfeit drugs circulating in
the US market adds urgency to ongoing efforts to improve
traceability in the medicines supply chain, and will also lend
weight to arguments against parallel trade in...
Researchers may have found a novel way to fight asthma by targeting
a protein that is centrally involved in the bronchial inflammation
and airway constriction that prompts asthma's hallmark symptoms.
The antibody treatment is...
Lonza has won a major new contract for its biopharmaceutical
manufacturing facility in Visp, Switzerland, making bulk actives
for Belgian company UCB, reports Phil Taylor.
Biosample management firm, GenVault announced an exclusive
agreement to acquire the full rights to a DNA labelling
intellectual property, which allows researchers to identify the
sample through its complete downstream analysis to...
Polychromix and Ocean Optics have formed a partnership that aims to
deliver cost-effective NIR spectroscopy solutions to a range of
industries including the pharmaceutical and food industry,
reports Wai Lang Chu.
According to a new report by the National Academies, the advent of
increased global competition for outstanding students and
scientists has heightened the need for a widespread effort to
attract high calibre researchers to the US.
Researchers in the US have developed a way to make large,
protein-based drugs suitable for oral rather than injectable
delivery by fusing them with a carrier molecule, reports Phil
Taylor.
French chemicals company Rhodia, already facing two separate
investigations for alleged accounting irregularities and insider
trading, has become embroiled in further legal fights just as it
starts to lift itself out of financial...
Biopharmaceutical company, Cytogen, and contract services provider
Dowpharma have announced a collaboration to create a targeted
oncology product designed to treat prostate and other cancers. The
new treatment also demonstrates the...
In-PharmaTechnologist.com presents a round up of personnel news in
the pharmaceutical sector, including the sudden departure of Susan
Vogt from Millipore.
According to a new report the therapeutic antibody market is
expected to treble in size by 2010 as significant leaps forward
coupled with safer and more effective humanised and fully human
antibodies are pouring onto the market fulfilling...
Medarex has announced the initiation of a phase I clinical trial of
its human monoclonal antibody for the treatment of ulcerative
colitis after the FDA granted the company an Investigational New
Drug (IND) application.
Peakdale Molecular and Dynamic Extractions are to collaborate on
the development of a new separation technology with applications in
drug discovery, development and manufacture.
Vertex Pharmaceuticals have announced the latest results that
indicate the investigational oral hepatitis C virus (HCV) protease
inhibitor VX-950 was well tolerated and demonstrated potent
antiviral activity in a Phase Ib clinical...
Canada's ATS Automation Tooling Systems has launched a
fully-automated inspection system for plastic containers used as
primary packaging for aseptically filled pharmaceutical products.
Wyatt Technology is set to offer its first integrated solution for
batch dynamic light scattering, which are amongst a batch of
products set to bring improved high throughput screening and better
understanding of the physical attributes...
Germany's Sartorius will distribute a novel disposable mixing
system developed by LevTech of the US that makes use of a novel
mixing impellor that levitates on a magnetic field, reports Phil
Taylor.
A pilot programme looking at how radiofrequency identification
(RFID) can be used in pharmacies to pick up counterfeit medicines
is to be developed into a commercial product, reports Phil
Taylor.
Beckman Coulter has announced the launch of its latest clinical
system, which aims to help clinical laboratories simplify and
automate chemistry testing and productivity whilst reducing overall
costs, reports Wai Lang Chu.
Swiss chemicals company Clariant saw its operating profit decline
by nearly a third as higher raw material costs took their toll,
although net profit rose 18 per cent, boosted by lower
restructuring charges compared to the same period...
Latin America shows considerable and untapped business potential
for the pharmaceutical industry, according to new research
conducted by PricewaterhouseCoopers.
Sangamo BioSciences has initiated a Phase I clinical trial for its
novel therapy for diabetic neuropathy that is designed to protect
and stimulate the regeneration of peripheral nerve function in
diabetics suffering from peripheral...
Roquette has introduced pyrogen-free versions of its sodium lactate
and sodium gluconate products for applications in the
pharmaceuticals industry, reports Phil Taylor.
US researchers think they have found promising new molecular
targets and treatment approaches for malignant brain tumours,
suggesting a new therapy for anti-cancer drugs.
A new way of ensuring that pharmaceutical production lines are free
of cleaning agents has been developed by Smiths Detection and Dober
Group, reports Phil Taylor.
The sudden departure of Merck & Co's chairman and chief
executive, Raymond Gilmartin, last week brings into sharp
perspective the difficulties facing the ailing US drugmaker,
reports Phil Taylor.
A new laboratory technique used by fruit fly geneticists for more
than a decade is now available to scientists studying genes and
diseases in mice. This technique offers a powerful new tool to
study genetics, particularly in disease.
A patent has been issued to Arena Pharmaceuticals for its small
molecule treatment for obesity, which targets a specific receptor,
thought to be involved in the regulation of food intake and may be
useful in pharmaceutical compositions...
Arrayjet launches a new inkjet microarray spotter, which uses a
modern, replaceable inkjet print head with over 100 nozzles to
deliver samples to the array surface. The non-contact technology
also has a unique replaceable inject print...
Italy's fine chemicals industry organisation, Afaquim, is
organising a conference in September aimed at coordinating the
efforts of European active pharmaceutical ingredient (API)
suppliers in the face of increasing competition...
Germany's chemical companies have reported improved sales and
earnings in the first quarter of the year, and are optimistic of an
improved operating environment through 2005, reports Phil
Taylor.
Bio-Tek Instruments and LI-COR Biosciences announce the integration
of Bio-Tek's Bio-Stack Microplate Stacker to LI-COR's new Aerius
Automated Infrared Imaging System, a microplate reader providing
automated data analysis...
Teva Pharmaceutical Industries' active pharmaceutical ingredients
(API) business is on track to become a $1 billion enterprise this
year, although growth in the first quarter of this year was almost
entirely from in-house sales,...
PANalytical, a supplier of analytical instrumentation and software
for X-ray diffraction and X-ray fluorescence spectrometry, has
expanded ibnto Asia with the opening of a Regional Application
Laboratory in Shanghai, China.
Canadian company Generex Biotechnology has stolen a march on its
larger rivals in the pharmaceutical industry by winning regulatory
approval for the world's first non-injectable insulin formulation,
reports Phil Taylor.
Charles River Laboratories saw a double-digit boost in fiscal first
quarter revenues reflecting a jump in operating earnings, helped by
its acquisition of Inveresk Research Group and the emerging trend
in outsourcing preclinical services.
RTS Life Science has unveiled two new sample storage products that
incorporate an integral cherry picking feature that can handle
plates, tubes and vials. The two product additions follow on from
RTS's small store, SmaRTStore...
Emerson Process Management has stepped up its efforts to sell its
engineering, process control and digital automation technologies
into the life sciences sector with the launch of a new programme,
called OpX, at the Interphex exhibition...
Canada's Alcan is opening a new production centre dedicated to
pharmaceutical packaging at its Alzira plant, located near Valencia
in Spain. The centre will specialise in printing flexible packaging
materials, reports Phil Taylor.
Eyetech Pharmaceuticals' latest study has demonstrated the
significance of VEGF164 in pathological neovascularisation,
providing further evidence of the therapeutic benefits of a VEGF
inhibitor that specifically targets an underlying...
Patients suffering from conditions as diverse as asthma and
diabetes could benefit from research at Cardiff University to
improve the effectiveness of drugs taken through spray inhalers.
In-PharmaTechnologist.com presents a round up of personnel news in
the pharmaceutical sector, including the speculation surrounding
the successor to Solvay's CEO.
VIRxSYS has announced the completion of the phase I study of its
novel HIV gene therapy, which has been touted as the first of a
next-generation anti-HIV treatment involving gene therapy. The
positive results mean a phase II study...
Qiagen has announced the acquisition of RNAture's nucleic acid
isolation products from Hitachi Chemical Research Centre. The
latest acquisition sees Qiagen purchase an extensive range of
products that addresses high-throughput...
UK-based contract researcher Synprotec has been acquired by India's
Dishman Pharmaceuticals & Chemicals in a move that marks a
continuing expansion of the latter firm into foreign markets,
reports Phil Taylor.
GlaxoSmithKline has announced plans to acquire the Corixa
Corporation, which represents an important strategic deal for GSK's
vaccines division, GSK Bio. The division is the only major vaccine
maker with active R&D programs...
Celera Genomics have filed an Investigational New Drug (IND)
application for a novel histone deacetylase (HDAC) inhibitor that
has proved effective in inhibiting cancer cell proliferation. The
filing also signifies Celera's transformation...
